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Several Ubr ubiquitin ligases recognize the N-terminal amino acid of substrate proteins and promote their degradation
via the Arg/N-end rule pathway. The primary destabilizing N-terminal amino acids in yeast are classified into type 1
(Arg, Lys, and His) and type 2 (Phe, Trp, Tyr, Leu, Ile, and Met-Ф) residues. The type 1 and type 2 residues bind to the
UBR box and the ClpS/N-domain, respectively, in canonical Ubr ubiquitin ligases that act as N-recognins. In this study,
the requirement for type 1 and type 2 amino acid recognition by Schizosaccharomyces pombe Ubr11 was examined
in vivo. Consistent with the results of previous studies, the ubr11Δ null mutant was found to be defective in
oligopeptide uptake and resistant to ergosterol synthesis inhibitors. Furthermore, the ubr11Δ mutant was also less
sensitive to some protein synthesis inhibitors. A ubr11 ClpS/N-domain mutant, which retained ubiquitin ligase
activity but could not recognize type 2 amino acids, phenocopied all known defects of the ubr11Δ mutant. However,
the recognition of type 1 residues by Ubr11 was not required for its functioning, and no severe physiological
abnormalities were observed in a ubr11 mutant defective in the recognition of type 1 residues. These results
reinforce the fundamental importance of the ClpS/N-domain for the functioning of the N-recognin, Ubr11.
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The N-end rule pathway is responsible for the ubiquiti-
nation of substrate proteins that harbor a destabilizing
amino acid at their N-terminus. The destabilizing amino
acid is an essential component of a degradation signal
known as the N-degron. A Ubr ubiquitin ligase, acting
as an N-recognin, binds to the N-terminal residue of
the N-degron and ubiquitinates the substrate protein,
thus targeting it for degradation by the proteasome
(Tasaki et al. 2012; Varshavsky 2011). Two independent
pathways, the Arg/N-end rule and the acetylated N-end
rule, have been described for this process. Ubr ubiquitin
ligases function only in the Arg/N-end rule pathway.
Arg/N-end rule N-recognin mutants of the yeasts,
Saccharomyces cerevisiae (ubr1) and Schizosaccharomyces
pombe (ubr11), grow almost normally. However, because
the Ubr proteins are required for the expression of
oligopeptide transporters, both mutants are defectiveCorrespondence: kkita@hiroshima-u.ac.jp
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in any medium, provided the original work is pin the uptake of extracellular oligopeptides (Byrd et al.
1998; Kitamura et al. 2012). The regulation of peptide
uptake has been well characterized in S. cerevisiae
(Turner et al. 2000; Du et al. 2002; Xia et al. 2008a, b;
Varshavsky 2011). After Ubr1 ubiquitinates and promotes
the degradation of the transcriptional repressor, Cup9,
the expression of the peptide transporter gene (PTR2)
is upregulated, and the cell becomes competent for
peptide uptake. The binding of the intracellular N-end
rule dipeptides to Ubr1 facilitates the recognition and
ubiquitination of Cup9 by Ubr1, and further accelerates
peptide uptake. Similarly, Ubr11 in S. pombe is essential
for the expression of the oligopeptide transporter genes,
ptr2 and isp4 (Kitamura et al. 2012). However, no Cup9
homolog has been found in the S. pombe genome, and the
Ubr11 substrate that represses peptide uptake in S. pombe
has not been identified. In the opportunistic pathogen,
Candida albicans, Ubr1 controls hyphal initiation through
the proteolysis of Cup9. However, it is not known whether
the degradation of Cup9 depends on the type of residue
present at its N-terminus (Lu et al. 2014). Similarly, thepen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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is necessary for virulence against wheat and maize;
however, the relevant substrate proteins are unknown
(Ridenour et al. 2013).
The classical primary destabilizing amino acid in the
N-degrons of the Arg/N-end rule pathway in yeast is
either a basic residue (type 1: Arg, Lys, or His) or a bulky
hydrophobic residue (type 2: Leu, Ile, Trp, Phe, or Tyr)
(Varshavsky 2011; Tasaki et al. 2012). An unacetylated
N-terminal methionine followed by a hydrophobic residue
(designated Met-Ф also functions as a type 2 N-degron
(Kim et al. 2014). Different regions within the canonical
Ubr N-recognin proteins bind to type 1 and type 2
amino acids (Xia et al. 2008b; Tasaki et al. 2009). Type
2 N-terminal amino acids bind to the N-domain, which is
homologous to the bacterial N-recognin, ClpS (Lupas and
Koretke 2003; Erbse et al. 2006; Tasaki et al. 2009). Similar
to the eukaryotic N-end rule pathway, ClpS is responsible
for the recognition of the same N-terminal type 2 amino
acids (except Ile) in the bacterial N-end rule pathway
(Erbse et al. 2006; Dougan et al. 2010). In contrast, type
1 N-terminal residues are recognized by the eukaryote-
specific UBR domain. In our previous studies, we inves-
tigated the roles of these domains and demonstrated the
importance of type 2 N-terminal amino acid recogni-
tion in peptide uptake, by mutating Ubr11 in S. pombe
(Kitamura and Fujiwara 2013). However, how the rec-
ognition of type 1 residues affects the in vivo function
of Ubr11 was not characterized.
In the present study, a Ubr11 mutant that was defective
only in the recognition of type 1 N-terminal amino acids
was engineered, and the effects of the mutation were
compared with those in a Ubr11 ClpS/N-domain mutant
defective in the recognition of type 2 residues. Importantly,
it was found that the recognition of type 2 residues by the
ClpS/N-domain was essential, but the recognition of type 1
residues by the UBR domain was dispensable for almost all
Ubr11 functions. These results contribute to our under-
standing of the structure-function relationship in canonical
Ubr ubiquitin ligases.
Results
Analysis of a ubr11 mutant defective in type 1 amino
acid recognition
The residues of bacterial ClpS that interact with the
hydrophobic N-degrons were identified in earlier stud-
ies (Wang et al. 2008; Román-Hernández et al. 2009;
Schuenemann et al. 2009). We previously characterized a
yeast strain that harbored a mutation within the conserved
ClpS/N-domain in S. pombe Ubr11. This ubr11-m3 mutant
(D251N, H254Y), which was renamed ubr11-T2 in this
study (Additional file 1: Figure S1) because of its ‘type
2-defective’ nature, lacked dipeptide uptake because
of its inability to express the Ptr2 peptide transporter(Kitamura and Fujiwara 2013). In the ubr11-T2 mu-
tant, which was unable to recognize type 2 residues,
the fluorescence intensity of the type 1 model substrate,
ArgNd-fused green fluorescent protein (ArgNd-GFP), was
low, similar to that in wild type Ubr11-expressing cells
(control profiles in Figure 1a). We previously demon-
strated that the fluorescence intensity reflects the pro-
tein amount of an N-degron, XaaNd bearing-GFP, and
that a low GFP level correlates with an intrinsic in-
stability of GFP, because of its N-end rule-dependent
proteolysis (Kitamura and Fujiwara 2013). Because the
N-end rule substrate and the N-end rule dipeptide
compete for the same binding site within Ubr11, proteoly-
sis via the N-end rule pathway is inhibited by dipeptides
that bear the same type of N-terminal amino acid as the
substrate. In contrast to the wild type Ubr11-expressing
cells, degradation was not inhibited by exogenous Lys-Leu
type 1 dipeptides in the ubr11-T2 mutant (Figure 1a, vector)
because it was defective in the expression of the Ptr2
dipeptide transporter (Kitamura and Fujiwara 2013).
However, when a multicopy plasmid was used to increase
the expression of Ubr11-T2, Lys-Leu dipeptides weakly
inhibited the degradation of ArgNd-GFP, although not
as effectively as in a strain expressing wild type Ubr11
(Figure 1a, right, and b; Additional file 2: Figure S2b).
Ubr11’s recognition of Lys-Leu is not affected by the
ubr11-T2 mutation itself (Kitamura and Fujiwara 2013).
Therefore, these results indicated that Ubr11-T2 was not
completely inactive, but its ability to induce peptide uptake
was severely compromised.
To complement the above findings and to further investi-
gate the relationship between N-terminal amino acid recog-
nition and peptide uptake, a Ubr11 mutant defective in the
recognition of type 1 residues was characterized. The
ubr11-m6 mutant (Asp117Ala; Additional file 1: Figure S1)
was tested first because the conserved aspartic acid inter-
acts with the type 1 N-terminal amino acid of substrate
proteins (Choi et al. 2010; Matta-Camacho et al. 2010). Fur-
ther, a corresponding mutation in mouse Ubr1 specifically
interferes with its ability to bind type 1 amino acids in vitro
(Tasaki et al. 2009). However, its functionality in vivo was
not tested. The mutant Ubr11-m6 protein was expressed
in the ubr11Δ strain from a multicopy plasmid, and its
functionality was monitored. Interestingly, the S. pombe
ubr11-m6 mutant was able to degrade both type 1 and type
2 model substrates (Additional file 2: Figure S2a and b)
and induce peptide uptake (Figure 2). Another mutant,
ubr11-T1 (Gly147Arg), was then examined because a
mutation of the corresponding residue in S. cerevisiae
Ubr1 produced a mutant that was defective in targeting
type 1 substrates (Xia et al. 2008b). This conserved glycine
is also located near the residue critical for type 1 N-end
recognition (Additional file 1: Figure S1). The type 1 model
substrate, ArgNd-GFP, was highly expressed in the S. pombe
Figure 1 Characterization of ubr11 mutants specifically defective in the recognition of N-terminal type 1 or type 2 residues. (a and b)
Each strain was cultured with or without the indicated dipeptide for 4 h. The relative fluorescence intensities of ArgNd-GFP and TrpNd-GFP, which
are type 1 and type 2 N-end rule substrates, respectively, were measured by flow cytometry. (a) The effect of Lys-Leu dipeptides was severely
compromised in the ubr11-T2 mutant. ubr11-T2, which has type 2 N-terminal residue-specific recognition defect (left and middle), or the ubr11Δ
(right) strains, which express ArgNd-GFP, were transformed with the indicated plasmid, and monitored for changes in the fluorescence intensity of
ArgNd-GFP. (b) Ubr11-T1 was specifically defective in the recognition of type 1 N-end residues. Each strain was examined as described in (a). (c)
The type 1 N-degron sequence in Rec8 did not promote Rec8c degradation in the ubr11-T1 strain. The X-Rec8c-GFP was expressed from the nmt
promoter. The steady state levels of the type 1 substrate, Arg-Rec8c-GFP (lanes 1 and 2), and the type 2 substrate, Trp-Rec8c-GFP (lanes 3–5), in
the indicated strains were examined by immunoblotting with anti-GFP antibody. Cdc2: loading control. (d) Amino acid sequences of the
N-degrons used in this study. The DYKDDDDK sequence shown in parenthesis is a FLAG tag epitope that was inserted before the GFP protein.
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file 2: Figure S2b), as in the control ubr11Δ strain (Figure 1b,
top left panel, vector; Additional file 2: Figure S2b). Incontrast, the fluorescence intensity of the type 2 substrate,
TrpNd-GFP, was low and its level increased when the type 2
dipeptide, Tyr-Leu, was added to strains expressing either
Figure 2 Uptake of dipeptides by the ubr11 mutants. A host strain (ubr11Δ leu1 ura4) was transformed with ura4+ plasmids encoding Ubr11
mutant or wild type proteins. Their ability to rescue the growth defect of the leucine auxotrophic host strain in the presence of leucine-containing
dipeptides was tested. Serially diluted cells were spotted on the medium containing the indicated peptides or leucine. The control medium lacked
any source of leucine. The ubr11-T1 mutation, which impaired recognition of type 1 residues, did not affect the utilization of the dipeptides. In contrast,
the type 2-specific ubr11-T2 mutant was mostly defective.
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ligase activity of Ubr11-T1 was not impaired, and the
ubr11-T1 mutant had a specific defect in type 1 residue
recognition, but responded normally to the type 2 dipep-
tide. For reasons that are still unclear, the fluorescence
intensity and protein levels of the type 2 substrate,
TrpNd-GFP, were partially increased when type 1 Lys-Leu
dipeptides were added to a strain expressing wild type
Ubr11 (Figure 1b, left profile shown in black; Additional
file 3: Figure S3a and b). However, Lys-Leu dipeptides
were not effective in the ubr11-T1 mutant (Figure 1b),
confirming that this mutant had lost the ability to
interact with type 1 N-terminal amino acids.
To exclude the possibility that the defect in the ubr11-T1
mutant was confined to the ArgNd N-degron, the stabil-
ity of another N-end rule substrate, bearing a different
N-degron, was examined. The C-terminal fragment of Rec8
(Rec8c), which is generated by a separase-mediated
cleavage of cohesin, is an endogenous substrate of the
Arg/N-end rule pathway in S. pombe (Fujiwara et al. 2013).
Although the N-degron sequence in Arg-Rec8c is
completely different from that in ArgNd (Figure 1d),
Arg-Rec8c-GFP (type 1 substrate), but not Trp-Rec8c-GFP
(type 2 substrate), was stabilized in the ubr11-T1 mutant
(Figure 1c). Therefore, it was concluded that the ubr11-T1
mutant was defective in the recognition of N-terminal type
1 amino acids in general.
Utilization of dipeptides by ubr11 mutants defective in
recognizing type 1 or type 2 residues
Subsequently, the ability of the mutants to support pep-
tide uptake was tested. All proteins were expressed in the
ubr11Δ host strain from a multicopy plasmid. Consistent
with our previous report (Kitamura et al. 2012), ubr11Δ
cells harboring the empty vector were defective in the up-
take of all dipeptides examined (Figure 2). Interestingly,
the uptake of all three dipeptides was not affected in theubr11-T1 mutant. However, the ubr11-T2 mutant plasmid
failed to rescue the growth when type 2 (Leu-Ala) or
non-N-end rule (Ala-Leu) dipeptides were used.
Growth could not be recovered even when soy peptides
(various soy-derived oligopeptides-enriched mixtures;
Kitamura et al. 2012) were used as a source of leucine.
Although a ubr11Δ strain harboring the multicopy
ubr11-T2 plasmid was able to utilize type 1 dipeptides
(Lys-Leu), a mutant strain, in which the genomic ubr11+
locus was replaced with the ubr11-T2 gene, failed to utilize
Lys-Leu (Kitamura and Fujiwara 2013). In conclusion,
Ubr11 stimulated dipeptide uptake even when it was
unable to recognize N-terminal type 1 amino acids. In
contrast, recognition of type 2 amino acids had a pivotal
role in peptide uptake.
Resistance of ubr11 mutants to protein synthesis inhibitors
When characterizing the ubr mutants, it was observed
that the ubr11Δ mutant showed weak resistance towards
low doses of protein synthesis inhibitors, such as aniso-
mycin and hygromycin B (Figure 3a). The expression of
two major oligopeptide transporters, Ptr2 and Isp4, is
very low in ubr11Δ cells (Kitamura et al. 2012). How-
ever, like the wild type strain, the ptr2Δ isp4Δ double
mutant was sensitive to both inhibitors, indicating that
the ubr11Δ mutant was inherently less sensitive to inhib-
ition of peptide synthesis, and that Ptr2 and Isp4 were
unrelated to the resistance. Next, the effect of type 1 and
type 2 recognition defects on the cells’ sensitivity to pro-
tein synthesis inhibitors was tested. Only the ubr11-T2
mutant, but not ubr11-T1, was resistant to anisomycin
(Figure 3b). Both the ubr11-T1 and the ubr11-T2 mutants
were resistant to hygromycin B at 40 μg/mL, though the
effect on Ubr11-T2 was more pronounced. These results
suggested that an impairment in the functionality of
the ClpS/N-domain affected the sensitivity towards these
protein synthesis inhibitors.
Figure 3 The ubr11-T2 mutant phenocopied ubr11Δ mutant for drug resistance. (a) Resistance of the ubr11Δ mutant to anisomycin and
hygromycin B (inhibitors of protein synthesis) and terbinafine (an inhibitor of ergosterol synthesis). Serially diluted cells of each strain were
spotted on drug-containing or drug-free (control) medium. Note that the strains shown in the second and fifth rows are intrinsically resistant to
hygromycin B because they contain the isp4::hphMX6 or ubr11::hphMX6 allele. (b) The host ubr11Δ strain was transformed with plasmids
encoding wild type or mutant Ubr11, and the sensitivity of the yeast to the inhibitors was examined as in (a). The ubr11Δ and ubr11-T2 strains
showed the same profiles, but the ubr11-T1 profile resembled that of the wild type strain.
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growth inhibitory effects of terbinafine
A ubr11Δ mutant was identified in a genome-wide screen
for mutants that were resistant to terbinafine and clotrima-
zole, both of which inhibit different steps of the ergosterol
synthetic pathway (Fang et al. 2012). Although the reason
for the resistance remains unclear, the resistance to terbi-
nafine was confirmed using an independently prepared
ubr11Δ strain; it was established that both Ptr2 and Isp4
were not responsible for the resistance (Figure 3a). Interest-
ingly, the ubr11-T2 ClpS/N-domain mutant was also resist-
ant to terbinafine, whereas cells expressing Ubr11-T1 or
the wild type protein were sensitive (Figure 3b), suggesting
that the integrity of the ClpS/N-domain is also important
for the response towards terbinafine.
Discussion
In this study, the relationship between the recognition of
N-terminal residues in the Arg/N-end rule pathway and
the in vivo function of the N-recognin, Ubr11, in S. pombe
was examined. The Arg/N-end rule pathway in yeast plays
an important role in the regulation of extracellular oligo-
peptide uptake by promoting the expression of peptide
transporters (Varshavsky 2011; Kitamura et al. 2012).
In S. cerevisiae, the Ubr1-dependent proteolysis of the
transcriptional repressor, Cup9, by the Arg/N-end rule
pathway is essential for peptide uptake (Turner et al.
2000; Du et al. 2002; Xia et al. 2008a). Curiously, Cup9
is neither a type 1 nor a type 2 N-end rule substrate(Xia et al. 2008b). The binding of N-end rule dipep-
tides to the N-recognin, Ubr1, increases the degrad-
ation of Cup9, thus further stimulating peptide uptake
(Turner et al. 2000). Interestingly, the S. pombe genome
does not encode a Cup9 homolog. In this study, in S. pombe,
the recognition of N-terminal type 1 amino acids was found
to be dispensable, whereas the recognition of type 2 amino
acids was found to be critical for the in vivo function of
Ubr11. Based on the results of this study, we can assume
that the N-end rule substrate required for peptide uptake in
S. pombe may be a type 2 substrate protein. However, the
identity of this protein remains unknown. Alternatively, the
ClpS/N-domain of Ubr11 may regulate peptide uptake by
recognizing an intracellular type 2 oligopeptide itself, rather
than a type 2 substrate protein.
To date, several regulators of cellular physiology, in-
cluding transcription factors that regulate hypoxic re-
sponses, caspase-generated pro-apoptotic protein fragments,
neurodegeneration-associated protein fragments, pro-
teolytic fragment of BRCA1 (breast cancer susceptibility
type 1 protein), and PINK1 (a Parkinson disease-related
mitochondrial protein) have been identified as substrates
of the Arg/N-end rule pathway in plants and mammals
(Gibbs et al. 2011; Licausi et al. 2011; Piatkov et al. 2012;
Xu et al. 2012; Brower et al. 2013; Yamamoto and Youle
2013). However, these proteins are not conserved in yeast.
In S. cerevisiae and S. pombe, other than the type 2 Met-Ф
degron-bearing proteins, whose N-termini are inherently
acetylated (Kim et al. 2014), only the C-terminal fragments
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counterpart, Rec8, have been identified as Arg/N-end
rule substrates whose degradation depends on the N-
terminal residue (Rao et al. 2001; Fujiwara et al. 2013).
The C-terminal fragments of Scc1 and Rec8, generated by a
separase-mediated cleavage during mitosis and meiosis, re-
spectively, bear a type 1 N-end residue. Inhibiting the deg-
radation of the Scc1 and Rec8 fragments is not deleterious
unless the proteins are strongly overexpressed from an
ectopic promoter (Rao et al. 2001; Fujiwara et al. 2013).
Taken together with our finding that a ubr11-T1 muta-
tion does not result in any apparent defects and that the
ubr11Δ mutant has no adverse phenotypes in meiosis
(Fujiwara et al. 2013), these observations suggest that
there may be no essential type 1 N-end rule substrates
that need to be degraded in S. pombe, at least in an unper-
turbed condition. It is still possible that the degradation of
an unidentified type 1 substrate is required for survival in
a specific condition. However, such drugs or conditions,
under which the ubr11 mutation results in deleterious ef-
fects in S. pombe, have not been encountered. Apparently,
the degradation of type 1 substrates by the Arg/N-end rule
pathway may have gained significance in higher eukaryotes
during the course of evolution.
Type 1 N-degrons appear to induce proteolysis more
potently than type 2 N-degrons in S. pombe (Kitamura
and Fujiwara 2013; Fujiwara et al. 2013). However, the
recognition of type 2 amino acids seems to play a more
important role than the recognition of type 1 residues,
as demonstrated in this study. Intriguingly, among the
canonical Ubr proteins, the ClpS/N-domain, which rec-
ognizes type 2 amino acids, is conserved only in genuine
N-recognins (Tasaki et al. 2012). The N-domain sequence
in Ubr proteins was originally identified on the basis of
its homology to a small bacterial N-recognin protein,
ClpS (Lupas and Koretke 2003; Erbse et al. 2006; Tasaki
et al. 2009). By incorporating the ClpS-like N-domain,
canonical Ubr N-recognins in eukaryotes acquired a
specialized role for the recognition of N-end residue in
the Arg/N-end rule pathway and, simultaneously, a means
to regulate peptide uptake. The binding region for type 1
residues is found within the eukaryote-specific UBR
domain that characterizes all Ubr proteins, including
the non-N-recognins and the non-canonical Ubr proteins
(mammalian Ubr3–Ubr7, S. pombe Ubr1, and S. cerevisiae
Ubr2) (Varshavsky 2011; Tasaki et al. 2012). Previous stud-
ies have shown that the degradation of type 2 N-end rule
substrates is stimulated in the presence of type 1 dipeptides
(Reiss et al. 1988; Gonda et al. 1989; Baker and Varshavsky
1991; Kwon et al. 2001). Considering this, an unexpected
observation in this study was that exogenous type 1 di-
peptides increased the amount of type 2 substrate. In
the case of TrpNd-GFP, an increase was observed for at
least two different type 1 dipeptides, Lys-Leu and Arg-Phe(Figure 1b, Additional file 3: Figure S3). In contrast, the type
2 dipeptide, Tyr-Leu, did not affect the levels of ArgNd-GFP,
a type 1 substrate (Kitamura and Fujiwara 2013). Although
the molecular mechanisms underlying this phenomenon
need to be elucidated in future studies, the current
data indicate that the recognition of type 2 substrates
by N-recognins is strongly influenced by the presence
of type 1 dipeptides in a complex manner.
Ubr ubiquitin ligases are necessary for protein quality
control (Eisele and Wolf 2008; Heck et al. 2010; Nillegoda
et al. 2010; Prasad et al. 2010; Khosrow-Khavar et al. 2012;
Theodoraki et al. 2012: Stolz et al. 2013; Summers et al.
2013; Kriegenburg et al. 2014). In both S. cerevisiae and
S. pombe, a mutation in the Ubr N-recognin alleviates
growth defects in several temperature-sensitive mutants
(Khosrow-Khavar et al. 2012; Kriegenburg et al. 2014).
In this study, it was found that the ubr11Δ mutant was
less sensitive to protein synthesis inhibitors than the
wild type strains, suggesting that Ubr11 also contributes
to quality control when partially defective proteins that
retain some residual function are produced in the pres-
ence of low concentrations of protein synthesis inhibi-
tors. Alternatively, substrates of Ubr11 may be required
for certain critical cellular processes that are more sen-
sitive to protein level alterations. In either case, inactiva-
tion of the Ubr11-dependent proteolysis of substrates
alleviates growth inhibition. Interestingly, in S. cerevisiae,
the quality control of several proteins is mediated by
the Arg/N-end rule pathway, in which an unacetylated
N-terminal methionine is recognized by the type 2
amino acid-binding site within Ubr1 (Kim et al. 2014).
However, other studies have shown that the role of the
Ubr proteins in quality control is independent of the N-end
rule pathway (Heck et al. 2010; Nillegoda et al. 2010).
Whether the Ubr proteins function as N-recognins or
act independently of the N-end rule pathway may depend
on the substrate protein. As shown in this study, the
ubr11 ClpS/N-domain mutant displayed altered responses
to several drugs. Whether these defects involve recog-
nition of substrates with type 2 N-end residues remains
to be determined.
Conclusions
Ubr11 N-recognin in Schizosaccharomyces pombe is a
conserved ubiquitin ligase, which is essential for the
degradation of substrate proteins harboring destabilizing
N-terminal amino acids (N-degron) via the Arg/N-end
rule pathway. The N-domain in Ubr11, which is homolo-
gous to the bacterial ClpS, recognizes bulky hydrophobic
amino acids at the N-terminus (type 2 N-degron). This
report described a ClpS/N-domain mutant, which did
not recognize type 2 N-end residues but retained ubiqui-
tin ligase activity towards type 1 substrates, phenocopied
the ubr11Δ null mutant. Specifically, the ClpS/N-domain
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(terbinafine) and protein synthesis (hygromycin B and ani-
somycin). These findings indicate that the ClpS/N-domain
has a general role in all cellular functions of the Ubr11
protein, in addition to its known role as a recognition
site for N-degron.
Materials and methods
Yeast strains and culture conditions
The yeast strains used in this study are listed in Additional
file 4: Table S1. Rich complete medium (YES) and synthetic
minimal medium (EMM2) were used for cell culture.
These media and other general yeast methods have been
described previously (Forsburg and Rhind 2006). Am-
monium chloride (the nitrogen source in EMM2) was
replaced with sodium glutamate (0.38% w/v) to evaluate
the sensitivity of yeast to anisomycin, hygromycin B, and
terbinafine. Dipeptides were purchased from Sigma-Aldrich
Japan (Tokyo, Japan), Bachem (Bubendorf, Switzerland),
and Kokusan Chemical Co. Ltd. (Tokyo, Japan), and used
at 0.2 mM (to support cell growth) or 5 mM (to inhibit
proteolysis). Hi-Nute HK soy peptides (provided by Ms.
Kitagawa, Fuji Oil, Osaka, Japan) were used at a concen-
tration of 0.1% (w/v).
To monitor proteolysis via the Arg/N-end rule path-
way, the GFP-tagged model substrates, XaaNd-GFP
and X-Rec8c-GFP, were used as described previously
(Fujiwara et al. 2013; Kitamura and Fujiwara 2013). To
express these proteins from the nmt promoter, the
cells were grown in thiamine-free EMM2 for at least
18 h at 28°C. To inhibit degradation via the Arg/N-end
rule pathway, the cells were treated with dipeptides for
3–5 h.
Plasmids
The ubr11-m6 (Asp117Ala) and ubr11-T1 (Gly147Arg)
mutants were synthesized as described previously by
inverse polymerase chain reaction using the Pk-ubr11+
template plasmid (Kitamura and Fujiwara 2013). After
sequence verification, each ubr11 gene, including the pro-
moter region, was excised by PstI digestion and inserted
into the PstI site of the pDblet vector (Brun et al. 1995).
The ubr11-T2 mutant, which does not recognize type
2 N-terminal residues, is identical to the ubr11-m3 mu-
tant, which we reported in previous studies (Kitamura and
Fujiwara 2013, Additional file 1: Figure S1). However, the
mutant was renamed ubr11-T2 in this study, to emphasize
its type-2 residue-specific defect.
Flow cytometry
The relative fluorescence intensities of ArgNd-GFP
and TrpNd-GFP were measured in 10000 live cells by
flow cytometry using a FACSCalibur™ flow cytometer
(Becton Dickinson, Franklin Lakes, NJ).Immunoblotting
Total cellular protein extracts were prepared and used
in immunoblotting experiments as described previ-
ously (Kitamura et al. 2011). Anti-GFP (GF200; Nacalai
Tesque, Kyoto, Japan) and anti-Cdc2 (sc-53; Santa Cruz
Biotechnology, Dallas, Texas) were used as the primary
antibodies.
Additional files
Additional file 1: Figure S1. Sequence alignments of Ubr boxes and
ClpS/N-domains. Residues that are identical and homologous in at least
three proteins are shown in red and blue, respectively. Highlighted in
black in the S. pombe Ubr11 are the residues mutated in this study. The type 1
and type 2 N-terminal amino acids of substrates or oligopeptides interact with
the residues marked by asterisks in the Ubr box and ClpS/N-domain,
respectively. Sp, Schizosaccharomyces pombe; Sc, Saccharomyces cerevisiae; Fv,
Fusarium verticillioides; Ca, Candida albicans; Mm, Mus musculus; Ec, Escherichia
coli; Cc, Caulobacter crescentus.
Additional file 2: Figure S2. Functionality of the ubr11 mutants. (a) The
ubr11-m6 mutant was functional. The ubr11Δ strains which expressed
ArgNd-GFP (left) or TrpNd-GFP (right) were transformed with an
autonomously replicating plasmid encoding the Ubr11-m6 protein, and
analyzed by flow cytometry. The GFP fluorescence levels were low in
untreated control cells due to proteolysis via the N-end rule pathway.
After 3 h of incubation in the presence of the dipeptides, the fluorescence
intensities increased to a level similar to that in wild type Ubr11 expressing
cells (Figure 1b). The peak to the right, with high fluorescence levels of
TrpNd-GFP, in the control culture may represent the population that lost the
plasmids because of their relatively unstable nature. (b) Functionality of the
type 1- and type 2-specific ubr11 mutants. The ArgNd-GFP-expressing ubr11Δ
strain was transformed with the empty vector (lane 1, Δ) or plasmids
directing the expression of each Ubr11 mutant protein (lanes 2–10). The cells
were cultured in the presence or absence of Lys-Leu dipeptides for 5 h, and
the GFP protein levels were compared by immunoblotting. The same extracts
were independently examined for the ubr11-T2 mutant (lanes 3, 4, 9, and 10).
Eight micrograms (lanes 1–8) and three micrograms (lanes 9 and 10) of total
cell extracts were used. Cdc2: loading control.
Additional file 3: Figure S3. The type 1 dipeptides induced an
increase in the TrpNd-GFP type 2 substrate protein levels. (a) Three wild
type strains expressing XaaNd-GFP from the same nmt1 promoter were
cultured for 5 h (TrpNd-GFP and MetNd-GFP) or 3 h (ArgNd-GFP) in the
presence or absence of the dipeptides indicated. Relative fluorescence
intensities in each culture were examined by flow cytometry.
Unexpectedly, TrpNd-GFP fluorescence, in addition to ArgNd-GFP
fluorescence, increased in response to two different type 1 dipeptides. In
contrast, the levels of MetNd-GFP, which is not a substrate of the N-end
rule pathway, were not affected by the dipeptides. Only the N-terminal
amino acids (Arg, Trp, and Met) are different among these three GFP
proteins, indicating that Lys-Leu did not generally affect the GFP levels.
(b) Total cell extracts were prepared from the same culture that was
analyzed in (a), and protein levels of TrpNd-GFP were examined by
immunoblotting.
Additional file 4: Table S1. Schizosaccharomyces pombe strains used in
this study.
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